Abbott Laboratories (ABT) Other Non Operating Income (2009 - 2026)

Abbott Laboratories has disclosed Other Non Operating Income across 18 years of filings, most recently posting $13.0 million for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $13.0 million, down 89.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $434.0 million (down 27.3% YoY), and the FY2025 annual result was $548.0 million, up 45.74% from the prior year.
• Other Non Operating Income came in at $13.0 million for Q1 2026 at Abbott Laboratories, down from $134.0 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $496.0 million in Q4 2023 to a low of -$19.0 million in Q3 2022.
• The 5-year median for Other Non Operating Income is $124.0 million (2024), against an average of $131.9 million.
• Across the five-year window, Other Non Operating Income plunged 300.0% in 2023 and jumped 1470.0% in 2025, its largest moves.
• Abbott Laboratories' Other Non Operating Income stood at $337.0 million in 2022, then soared by 47.18% to $496.0 million in 2023, then declined by 27.62% to $359.0 million in 2024, then sank by 62.67% to $134.0 million in 2025, then sank by 90.3% to $13.0 million in 2026.
• The last three Other Non Operating Income figures came in at $13.0 million (Q1 2026), $134.0 million (Q4 2025), and $150.0 million (Q3 2025), per Business Quant data.